Abstract

This report presents the health economic analyzes informing the recommendation of herpes zoster vaccination for adults with increased risk for disease.

  • Background paper
  • Europe
  • Sweden
  • Risk group
  • economic studies
  • cost effectiveness
  • budget impact
  • Herpes zoster